Andreas Busch
Corporate Officer/Principal bei ABSCI CORPORATION
Vermögen: - $ am 30.04.2024
Aktive Positionen von Andreas Busch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ABSCI CORPORATION | Corporate Officer/Principal | 04.10.2022 | - |
Director/Board Member | 17.03.2022 | 04.10.2022 |
Karriereverlauf von Andreas Busch
Ehemalige bekannte Positionen von Andreas Busch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CENTOGENE N.V. | Director/Board Member | 18.02.2022 | 12.12.2023 |
CYCLERION THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2021 | 30.09.2022 |
Corporate Officer/Principal | 29.04.2019 | 01.01.2021 | |
SHIRE | Chief Tech/Sci/R&D Officer | 01.01.2018 | 01.03.2019 |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | 01.01.2016 | 01.12.2017 |
Aventis Pharma AG | Corporate Officer/Principal | 01.01.2005 | 01.01.2005 |
Sanofi-Aventis Groupe SA
Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Corporate Officer/Principal | 01.01.1997 | 01.01.2005 |
Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | 01.01.1997 | 01.01.1999 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Director/Board Member | - | - |
░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Andreas Busch
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Statistik
International
Deutschland | 7 |
Vereinigte Staaten | 4 |
Irland | 2 |
Operativ
Corporate Officer/Principal | 8 |
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ABSCI CORPORATION | Health Technology |
CYCLERION THERAPEUTICS, INC. | Health Technology |
CENTOGENE N.V. | Commercial Services |
Private Unternehmen | 7 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Bayer HealthCare AG
Bayer HealthCare AG Pharmaceuticals: MajorHealth Technology Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany. | Health Technology |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Aventis Pharma AG | |
Hoechst Marion Roussel, Inc. | |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
Sanofi-Aventis Groupe SA
Sanofi-Aventis Groupe SA Financial ConglomeratesFinance Sanofi-Aventis Groupe SA operates as a holding company, with interest in the manufacture and distribution of pharmaceutical products. The company was founded on December 19, 1995 and is headquartered in Paris, France. | Finance |
- Börse
- Insiders
- Andreas Busch
- Erfahrung